Relative bioavailability of salbutamol to the lung following inhalation using metered dose inhalation methods and spacer devices.
about
Generics, chemisimilars and biosimilars: is clinical testing fit for purpose?Randomised controlled study of clinical efficacy of spacer therapy in asthma with regard to electrostatic chargeEvaluation of the community pharmacist's behavior towards a prescription of antidiabetic and antiasthma drugsMethods to identify drug deposition in the lungs following inhalationRelative bioavailability of terbutaline to the lung following inhalation, using urinary excretionEarly lung absorption profile of non-CFC salbutamol via small and large volume plastic spacer devicesDetermination of the relative bioavailability of salbutamol to the lungs and systemic circulation following nebulizationEffect of plastic spacer handling on salbutamol lung deposition in asthmatic children.Evaluating inhaler use technique in COPD patientsEvaluation of the use of inhaled medications by hospital inpatients with chronic obstructive pulmonary diseaseRelative bioavailability of sodium cromoglycate to the lung following inhalation, using urinary excretionThe Bioavailability of Salbutamol in Urine via Volumatic and Nonvolumatic Valved Holding ChambersVolumatic usage: some generic salbutamol metered dose inhalers can be used.Aerosol delivery systems for bronchial asthmaEstablishing bioequivalence for inhaled drugs; weighing the evidence.Pharmacokinetic properties and bioequivalence of orally inhaled salbutamol in healthy Chinese volunteers.Bioavailability of salbutamol.Pharmacokinetics of andolast after administration of single escalating doses by inhalation in mild asthmatic patients.Relative lung and systemic bioavailability of sodium cromoglycate inhaled products using urinary drug excretion post inhalation.The topical study of inhaled drug (salbutamol) delivery in idiopathic pulmonary fibrosis.A review of the in vitro and in vivo valved holding chamber (VHC) literature with a focus on the AeroChamber Plus Flow-Vu Anti-static VHC.Spirometry with bronchodilator test: effect that the use of large-volume spacers with antistatic treatment has on test response.Characterization of Medical Aerosols: Physical and Clinical Requirements for New Inhalers
P2860
Q27023707-97AB9680-2192-4DED-9D27-B37A89978638Q28346185-E9FE9A8B-EF27-4E85-944C-8A2B0B09E44FQ34045520-443F79EC-1D3D-4C56-8CF9-4400C96C0B9AQ34229278-02422293-5D4A-482D-9B1E-28A69EACC174Q34830183-35571C97-4A79-46B6-AEED-B19532D74E86Q35803061-05F5138E-2D08-4B69-ABB4-6EAB4A167B1DQ35803959-FE0F5FA5-19FD-43BD-BD01-7E963E3B2268Q35804135-842B6FE8-FF63-40CA-A97C-98CBF99AB263Q35849367-3F33F3F6-4173-4565-B880-165ABEBEC58BQ35898535-171FBFC7-C1E5-423C-B236-44869788AF15Q36053468-37807603-5338-44AF-BFE8-3563C893E272Q36370935-FFB327D1-A338-4ECD-AC20-7D0B6FA31AA3Q36577845-1BFFCBCD-047E-4084-9ED4-DEB408FD5370Q36680598-66424E94-775A-46D2-9F32-C27198148088Q37893662-AAD0948C-A576-41CD-A264-70568AA5095CQ39176996-19874351-181C-41D6-AEEC-7E3F17FB2947Q42415243-7432ED5E-396B-44B0-9AEA-1E207E60AE8FQ43824939-F1D752E9-F461-41E5-B95E-BE2AB4B1FDE3Q43996962-55A2DC16-8CDC-478E-8FC7-545C8D6660E9Q48096415-80B7FF68-CCC5-493B-945E-3B25763DE9D0Q49600518-2157F922-6C0F-4362-B663-72F72D84E731Q50976159-B43655A2-B9ED-4F17-9021-C317E35FA170Q58256462-2EAAACE5-4BE0-462E-8EF7-4FC6CECF317B
P2860
Relative bioavailability of salbutamol to the lung following inhalation using metered dose inhalation methods and spacer devices.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Relative bioavailability of sa ...... on methods and spacer devices.
@ast
Relative bioavailability of sa ...... on methods and spacer devices.
@en
type
label
Relative bioavailability of sa ...... on methods and spacer devices.
@ast
Relative bioavailability of sa ...... on methods and spacer devices.
@en
prefLabel
Relative bioavailability of sa ...... on methods and spacer devices.
@ast
Relative bioavailability of sa ...... on methods and spacer devices.
@en
P2860
P356
P1433
P1476
Relative bioavailability of sa ...... ion methods and spacer devices
@en
P2093
H Chrystyn
P2860
P304
P356
10.1136/THX.49.6.549
P407
P577
1994-06-01T00:00:00Z